Engineering Antibodies into Targeted Chimeras: From Recognition Modules to Programmable Degraders

Kaige Chen1,2,3, Quanyin Hu1,2,3,4

  • 1Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Summary

Antibody-associated targeted chimeras (AbTACs) leverage antibodies for targeted protein degradation. This review explores AbTAC evolution, platforms, and design principles for next-generation biologic degraders.